(Q42242318)

19 October 2017

title

Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination (English)

1 reference

19 October 2017

8

Camille Locht

1 reference

19 October 2017

Kaatje Smits

1

1 reference

19 October 2017

Gaelle Pottier

2

1 reference

19 October 2017

Julie Smet

3

1 reference

19 October 2017

Violette Dirix

4

1 reference

19 October 2017

Françoise Vermeulen

5

1 reference

19 October 2017

Iris De Schutter

6

1 reference

19 October 2017

Maria Carollo

7

1 reference

19 October 2017

Clara Maria Ausiello

9

1 reference

19 October 2017

Françoise Mascart

10

1 reference

19 October 2017

language of work or name

English

0 references

publication date

29 October 2013

1 reference

19 October 2017

1 reference

19 October 2017

volume

32

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

111-118

1 reference

Pertussis re-emergence in the post-vaccination era

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Priming with whole-cell versus acellular pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Pertussis control: time for something new?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Rationale for pertussis booster vaccination throughout life in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Why do pertussis vaccines fail?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

What's wrong with acellular pertussis vaccines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Re-emergence of pertussis: what are the solutions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Waning immunity to pertussis following 5 doses of DTaP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Immunity to the respiratory pathogen Bordetella pertussis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Immunity to Bordetella pertussis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Pertussis: a matter of immune modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Evaluation of efficacy in terms of antibody levels and cell-mediated immunity of acellular pertussis vaccines in a murine model of respiratory infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Modulation of the infant immune responses by the first pertussis vaccine administrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

T-cell quality in memory and protection: implications for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Antigen-specific responses assessment for the evaluation of Bordetella pertussis T cell immunity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

SPICE: exploration and analysis of post-cytometric complex multivariate datasets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Specific immunoglobulin for treatment of whooping cough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Induction of Bordetella pertussis-specific immune memory by DTPa vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Both CD4⁺ and CD8⁺ lymphocytes participate in the IFN-γ response to filamentous hemagglutinin from Bordetella pertussis in infants, children, and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.056

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2013.10.056

1 reference

19 October 2017

1 reference